Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Tocilizumab

Brand: 
NICE TA: 238
Indication: Systemic Juvenile Idiopathic Arthritis (NICE TA238)
Disease category: Musculoskeletal and joint disease
Commissioning responsibility: CCG
PbR excluded: Yes

Background

LMMG is adopting the local decision made prior to April 2013

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA238 - Tocilizumab for the treatment of systemic juvenile idiopathic arthritis  

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red